Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...

Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears ...

Kenvue (KVUE) reported a net profit margin of 9.4%, up from 7.3% last year. One-year earnings growth reached 26.3%, and the ...

D.E. Shaw, one of the Tylenol-maker’s largest shareholders, stood to lose over $200 million but is now expected to break even ...

Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.

Kenvue stock has struggled this year, but an acquisition offer is giving investors hope leading up to this week's earnings ...